Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT02003924

Public ClinicalTrials.gov record NCT02003924. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 14, 2026, 10:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PROSPER: A MULTINATIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.

Study identification

NCT ID
NCT02003924
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,401 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 30, 2013
Primary completion
Jun 27, 2017
Completion
Nov 27, 2025
Last update posted
Jan 26, 2026

2013 – 2025

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Urological Associates of Southern Arizona, PC Tucson Arizona 85741
Ronald Reagan UCLA Medical Center Los Angeles California 90095
UCLA Clark Urology Center Los Angeles California 90095
University of California, Irvine Medical Center Orange California 92868
Urology Associates of San Luis Obispo, a Medical Group, Inc San Luis Obispo California 93405
Urology Associates, P.C. Englewood Colorado 80113
c/o Lynn Buchwalder New Haven Connecticut 06510
C/O Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut 06510
Smilow Cancer Center at Yale New Haven-Hospital New Haven Connecticut 06510
Yale New Haven Hospital New Haven Connecticut 06510
Yale University School of Medicine New Haven Connecticut 06520
Lakeland Regional Cancer Center Lakeland Florida 33805
Urology of Indiana, LLC Carmel Indiana 46032
First Urology, PSC Jeffersonville Indiana 47130
IU Health Arnett Cancer Care Lafayette Indiana 47904
Kansas City Urology Care, PA Overland Park Kansas 66211
GU Research Network/ Wichita Urology Group Wichita Kansas 67226
Chesapeake Urology Research Associates Baltimore Maryland 21237
University of Michigan Health System Ann Arbor Michigan 48109
Michigan Institute of Urology Troy Michigan 48084
GU Research Network Omaha Nebraska 68130
Brooklyn Urology Research Group Brooklyn New York 11201
Premier Medical Group of the Hudson Valley Newburgh New York 12550
Duke University Medical Center Cary North Carolina 27518
Carolina Urology Partners, PLLC Charlotte North Carolina 28277
Carolina Urology Partners, PLLC Gastonia North Carolina 28054
Gaston Medical Associates Gastonia North Carolina 28054
Carolina Urology Partners, PLLC Huntersville North Carolina 28078
Duke Women's Cancer Care Raleigh Raleigh North Carolina 27607
Clinical Research Solutions Middleburg Heights Ohio 44130
Oregon Urology Institute Springfield Oregon 97477
Lancaster Urology Lancaster Pennsylvania 17604
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Vanderbilt University Medical Center, Dept. of Urologic Surgery Nashville Tennessee 37232
Vanderbilt University Medical Center, The Urologic Clinic Nashville Tennessee 37232
Urology San Antonio San Antonio Texas 78229
Urology of Virginia, PLLC Virginia Beach Virginia 23462

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 360 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02003924, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2026 · Synced Sep 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02003924 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →